Journal: Nature Communications
Article Title: An antimicrobial peptide as a potential therapy for bacterial pneumonia that alleviates antimicrobial resistance
doi: 10.1038/s41467-025-65449-w
Figure Lengend Snippet: a , b RP-HPLC analysis of AMP 1003 and (WRK)4 after incubation with trypsin, chymotrypsin and pepsin for 6 h at 37 °C. MICs of AMP 1003 against MRSA ATCC 33591 and K. pneumoniae ATCC 700603 in the presence of trypsin ( c ), chymotrypsin ( d ), pepsin ( e ), Na + ( f ), Mg 2+ ( g ), mouse serum ( h ), FBS ( i ) and NBCS ( j ). Source data are provided as a Source Data file.
Article Snippet: Accordingly, the antimicrobial activity of AMP 1003 in mouse serum (Fig. ), Fetal Bovine Serum (FBS) (Fig. ), and Special Newborn Calf Serum (NBCS) (Fig. ) against MRSA ATCC 33591 and K. pneumoniae ATCC 700603 was assessed.
Techniques: Incubation